{"nct_id":"NCT03052608","title":"A Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2024-12","start_date":"2017-04-27","start_date_type":"ACTUAL","primary_completion_date":"2020-03-20","primary_completion_date_type":"ACTUAL","completion_date":"2028-12-31","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["PFE"]}